Autologous EBV-specific Cytotoxic T Cells in Systemic Lupus Erythematosus: An Innovative Phase I/IIa Clinical Trial

被引：0
|
作者：
Enfrein, Antoine [1 ]
Clemenceau, Beatrice [2 ]
Saiagh, Soraya [3 ]
Bressollette, Celine [4 ]
Amoura, Zahir [5 ]
Vie, Henri [2 ]
Hamidou, Mohamed [1 ]
机构：
[1] CHU Nantes, Med Interne, Nantes, France
[2] Univ Nantes, Inserm U1232, Nantes, France
[3] CHU Nantes, Unite Therapie Cellulaire & Genique, Nantes, France
[4] CHU Nantes, Lab Virol, Nantes, France
[5] Hop La Pitie Salpetriere, AP HP, Med Interne, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页码：3691 / 3691
页数：1
相关论文
共 50 条
  • [21] EBV-related PTLD after kidney transplantation: Successful treatment with a tailored regimen including autologous EBV-specific cytotoxic T lymphocytes.
    Comoli, P
    Maccario, R
    Valente, U
    Labirio, M
    Basile, G
    Garaventa, A
    Nocera, A
    Perfumo, F
    Locatelli, F
    Ginevri, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 250 - 251
  • [22] Autologous EBV-specific cytotoxic T lymphocyte (CTL) infusions as early intervention for liver transplant recipients with lymphoproliferative disease.
    Savoldo, B
    Huls, HM
    Lopez, T
    Caldwell, YL
    Finegold, MJ
    Goss, J
    Karpen, SJ
    Gee, A
    Brenner, MK
    Rooney, CM
    Heslop, HE
    BLOOD, 2002, 100 (11) : 363A - 364A
  • [23] Quantitative analysis of EBV-specific T cells in retrovirally transduced donor leukocytes after stimulation with mitogens or autologous EBV-BLCL.
    Koehne, G
    Gallardo, HF
    Sadelain, M
    O'Reilly, RJ
    BLOOD, 1999, 94 (10) : 418B - 418B
  • [24] A novel approach to generate (ex vivo) EBV-specific cytotoxic T cells from a naive immunocompetent EBV-negative individual
    Metes, D
    Zeevi, A
    Nalesnik, MA
    Storkus, W
    Fung, JJ
    Rao, AS
    TRANSPLANTATION, 1999, 67 (07) : S234 - S234
  • [25] Role of T cells in EBV-infected systemic lupus erythematosus patients - The authors respond
    Gross, AJ
    Thorley-Lawson, D
    JOURNAL OF IMMUNOLOGY, 2005, 175 (06): : 3461 - 3461
  • [26] Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children
    Comoli, P.
    Ginevri, F.
    Maccario, R.
    Frasson, C.
    Valente, U.
    Basso, S.
    Labirio, M.
    Huang, G. -C.
    Verrina, E.
    Baldanti, F.
    Perfumo, F.
    Locatelli, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (09) : 2169 - 2176
  • [27] Clinical relevance of T follicular helper cells in systemic lupus erythematosus
    Nakayamada, Shingo
    Tanaka, Yoshiya
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (10) : 1143 - 1150
  • [28] Adoptive transfer of CMV- and EBV- specific peptide-stimulated T cells after allogeneic stem cell transplantation: A Phase I/IIa clinical trial
    Aigner, Michael
    Gary, Regina
    Moosmann, Andreas
    Maas, Stefanie
    Strobl, Julian
    Zimmermann, Robert
    Zingsem, Jurgen
    Kremer, Anita
    Mackensen, Andreas
    Gerbitz, Armin
    CANCER RESEARCH, 2017, 77
  • [29] Autologous EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in pediatric patients after liver transplantation
    Liu, J. -Y.
    Cui, T. -T.
    Wei, L.
    Zhu, Z. -J.
    Sun, L. -Y.
    LIVER TRANSPLANTATION, 2024, 30 : 174 - 175
  • [30] Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection
    Savoldo, B
    Huls, MH
    Liu, ZS
    Okamura, T
    Volk, HD
    Reinke, P
    Sabat, R
    Babel, N
    Jones, JF
    Webster-Cyriaque, J
    Gee, AP
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 2002, 100 (12) : 4059 - 4066
12345